Nomura Asset Management Co. Ltd. trimmed its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 6.7% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 161,802 shares of the pharmacy operator’s stock after selling 11,606 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Walgreens Boots Alliance were worth $11,750,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Andra AP fonden lifted its holdings in shares of Walgreens Boots Alliance by 6.9% in the 3rd quarter. Andra AP fonden now owns 62,300 shares of the pharmacy operator’s stock worth $4,811,000 after acquiring an additional 4,000 shares during the last quarter. Chesley Taft & Associates LLC lifted its holdings in shares of Walgreens Boots Alliance by 48.6% in the 4th quarter. Chesley Taft & Associates LLC now owns 261,369 shares of the pharmacy operator’s stock worth $18,981,000 after acquiring an additional 85,423 shares during the last quarter. First Trust Advisors LP lifted its holdings in shares of Walgreens Boots Alliance by 10.3% in the 4th quarter. First Trust Advisors LP now owns 748,421 shares of the pharmacy operator’s stock worth $54,350,000 after acquiring an additional 69,650 shares during the last quarter. CI Investments Inc. bought a new stake in shares of Walgreens Boots Alliance in the 3rd quarter worth about $27,555,000. Finally, Griffin Asset Management Inc. lifted its holdings in shares of Walgreens Boots Alliance by 10.6% in the 3rd quarter. Griffin Asset Management Inc. now owns 95,032 shares of the pharmacy operator’s stock worth $7,338,000 after acquiring an additional 9,090 shares during the last quarter. 61.00% of the stock is owned by institutional investors.
Walgreens Boots Alliance Inc (NASDAQ:WBA) traded up $0.19 during trading hours on Friday, hitting $67.57. 10,224,819 shares of the stock traded hands, compared to its average volume of 4,854,649. Walgreens Boots Alliance Inc has a twelve month low of $63.82 and a twelve month high of $87.79. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.47 and a current ratio of 0.96. The company has a market cap of $66,751.27, a price-to-earnings ratio of 18.67, a P/E/G ratio of 1.11 and a beta of 1.21.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, beating the consensus estimate of $1.27 by $0.01. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The business had revenue of $30.74 billion during the quarter, compared to analyst estimates of $30.39 billion. During the same quarter in the previous year, the business posted $1.10 EPS. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. sell-side analysts expect that Walgreens Boots Alliance Inc will post 5.79 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Monday, March 12th. Stockholders of record on Thursday, February 15th were given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.37%. The ex-dividend date was Wednesday, February 14th. Walgreens Boots Alliance’s payout ratio is currently 44.20%.
In other news, insider Stefano Pessina acquired 98,858 shares of the business’s stock in a transaction dated Monday, January 15th. The shares were purchased at an average price of $76.07 per share, with a total value of $7,520,128.06. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 14.80% of the stock is owned by insiders.
WBA has been the subject of several analyst reports. Deutsche Bank initiated coverage on shares of Walgreens Boots Alliance in a report on Monday, December 4th. They issued a “hold” rating and a $78.00 target price for the company. Vetr upgraded shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a report on Tuesday, December 12th. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $82.00 price objective for the company in a report on Saturday, January 13th. Robert W. Baird reiterated a “buy” rating and set a $82.00 price objective on shares of Walgreens Boots Alliance in a report on Thursday, January 4th. Finally, Mizuho set a $87.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a report on Wednesday, January 24th. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the stock. Walgreens Boots Alliance presently has an average rating of “Buy” and a consensus price target of $84.75.
COPYRIGHT VIOLATION NOTICE: “Walgreens Boots Alliance Inc (NASDAQ:WBA) Shares Sold by Nomura Asset Management Co. Ltd.” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/03/17/nomura-asset-management-co-ltd-sells-11606-shares-of-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.